13/10/2009 (Agence Europe) - At the press conference following the Health Council in Luxembourg on Monday 12 October, Commissioner Androulla Vassiliou said that two of the three laboratories (Ed: Novartis, GSK and Baxter) which had been granted marketing authorisation for their vaccines against flu A(H1N1) would, within the week, submit a request to the European Medicines Agence (EMEA) for a recommendation that one single injection is sufficient. “The third (Baxter) is expected to follow...